ARDS

Zydus’ Desidustat efficacious in treating hypoxia in Mexico’s hospitalised COVID-19 patients: Study

Read more

Zydus Cadila files IND application for ZYIL1, NLRP3 inflammasome inhibitor

Read more

USFDA approves IND application from Reven Pharma for Rejuveinix to treat COVID-19

Read more

USPTO grants patent to Tiziana for fully human monoclonal antibody, TZLS-501

Read more

Anti-TNF therapies could treat patients with COVID-19-related ARDS

Read more

Shiv Nadar University develops molecule with potential to cure COVID-19

Read more